This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ablin, J. N., Cohen, H., & Buskila, D. (2006). Mechanisms of disease: genetics of fibromyalgia. Rheumatology, 2, 671–678.
Anderberg, U. M., Marteinsdottir, I., & Knorring, L. von. (2000). Citalopram in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study. European Journal of Pain, 4, 27–35.
Arnold, L. M., Hudson, J. I., Hess, E. V., Wure, A. E., Fritz, D. A., Auchenback, M. B., et al. (2004). Family study of fibromyalgia. Arthritis and Rheumatism, 50, 944–952.
Arnold, L. M., Keck, P. E., & Welge, J. A. (2000). Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics, 41, 104–113.
Baranzini, S. E., & Oksenberg, J. R. (2005). Genomics and new targets for multiple sclerosis. Pharmacogenomics, 6, 151–161.
Chofflon, M. (2005). Mechanisms of action for treatments in multiple sclerosis. BioDrugs, 19, 299–308.
Cohen, H., Hagit, B., Neumann, J., & Ebstein, R. P. (2002). Confirmation of an association of fibromyalgia and serotonin transporter promoter region polymorphism, and relationship to anxiety related personality traits. Arthritis and Rheumatism, 46, 645–847.
Confavreux, C., Hutchinson, M., Hours, M., Hours, M. M., Cortinovis-Tourniaire, P., & Moreau, T. (1998). Rate of pregnancy-related relapse in multiple sclerosis. New England Journal of Medicine, 339, 285–289.
Coyle, P., Christie, S., Fodor, P., Fuchs, K., Glesser, B., Gutierrez, A., et al. (2004). Multiple sclerosis gender issues: clinical practices of women neurologists. Multiple Sclerosis, 10, 582–588.
Crofford, L. J., Russell, J., & Mease, P. (2002). Pregabalin improves pain associated with fibromyalgia syndrome in a multicenter, randomized, placebo-controlled monotherapy trial. Arthritis and Rheumatism, 46, suppl. S613.
Davis, S. N., Galassetti, P., Waserman, D. H., & Tate, D. (2000). Effects of gender on neuroendocrine and metabolic counter regulatory responses to exercise in normal men. Journal of Clinical Endocrinology and Metabolism, 85, 224–230.
Dessein, P. H., Shipton, E. A., & Stanwix, A. E. (2000). Neuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: a promising paradigm? Pain, 86, 213–215.
El-Etr, M., Vukusic, S., Gignoux, L., Durand-Dubiet, F., Achiti, I., Baulieu, E. E., et al. (2005). Steroid hormones in multiple sclerosis. Journal of the Neurological Sciences, 233 49–54.
Ferrero, S., Pretta, S., & Regani, N. (2004). Multiple sclerosis: management issues during pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 115, 3–9.
Frank, B., Niesler, B., Bondy, B., Spath, M., Pongratz, D. E., Achenheil, M., et al. (2004). Mutational analysis of serotonin receptor genes HTR3A and HTR3B in fibromyalgia patients. Clinical Rheumatology, 23, 338–344.
Friedberg, F., & Jason, L. A. (2001). Chronic fatigue syndrome fibromyalgia: Clinical assessment and treatment. Journal of Clinical Psychology, 57, 433–455.
Gandhi, N., DePauw, K. P., Dolny, D. G., & Freson, T. (2002). Effect of an exercise program on quality of life of women with fibromyalgia. Women and Therapy, 25, 91–103.
Goldenberg, D. L., Burckhardt, C., & Crofford, L. (2004). Management of fibromyalgia syndrome.Journal of the American Medical Association, 292, 2388–2395.
International Multiple Sclerosis Genetics Consortium. (2008). Risk alleles for MS identified by a genomewide study. New England Journal of Medicine, 357, 851–862.
Kajantie, E., & Phillips, D. W. (2006). The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology, 31, 151–178.
Kirschbaum, C., Kudielka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999). Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosomatic Medicine, 61, 154–162.
Koch, S., Goedde, R., Nigmatov, V., Epplen, J. T., Muller, N., Seze, J. de, et al. (2005). Association of multiple sclerosis with ILT6 deficiency. Genes and Immunity, 6, 445–447.
Koenig, H., Schumacher, M., Ferazz, B., Thi, A. N., Ressouches, A., Guemoun, R., et al. (1995). Progesterone synthesis and myelin formation by Schwann cells. Science, 268, 1500–1503.
Mastorakos, G., & Ilias, L. (2003). Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Annals of New York Academy of Sciences, 997, 136–149.
Mease, P. (2005). Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. Journal of Rheumatology, 32, 621.
Offenbaecher, M., Bondy, B., deJonge, S., Glatzeder, K., Kruger, M., Schoeps, P., et al. (1999). Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis and Rheumatism, 42, 2482–2488.
Oksenberg, J. R., Baranzini, S. E., Barcellos, L. F., & Hauser, S. L. (2001). Multiple sclerosis: genomic rewards. Journal of Neuroimmunology, 113, 171–184.
Oksenberg, J. R., & Barcellos, L. F. (2005). Multiple sclerosis: leaving no stone unturned. Genes and Immunity, 6, 375–387.
Orton, S., Herrera, B., Valdar, W., Ramagoplan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006). Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet, 5, 932–936.
Otte, C., Hart, S., Neylan, T. C., Marmar, C. R., Yaffe, K., & Mohr, D. C. (2005). A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology, 30, 80–91.
Pohl, D., Krone, B., & Rostasy, K. (2006). High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology, 67, 2063–2065.
Pozzili, C., Falaschi, P., Mainero, C., Martocchia, A., D’Urso, R., & Poroietti, A. (1999). MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology, 53, 622–624.
Ransohoff, R. M. (2007). Natalizumab for multiple sclerosis. New England Journal of Medicine, 356, 2622–2629.
Richards, S. C., & Scott, D. L. (2002). Prescribed exercise in people with fibromyalgia: parallel group randomized control trail. British Medical Journal, 325, 185.
Rossy, L. A., Bickelew, S. P., Dorr, N., Hagglund, K. J., Thayer, J. F., McIntosh, M. J., et al. (1999). A meta-analysis of fibromyalgia treatment interventions. Annals of Behavioral Medicine, 21, 180–191.
Russler, K. J., & Nemeroff, C. B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety, 12, 2–19.
Sandberg-Wollheim, M., Frank, D., Goodwin, T. M., Gisser, B., Lopez-Bresnahan, M., Stam-Moraga, M., et al. (2005). Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology, 65, 802–806.
Sarzi-Puttini, P., Atzeni, F., Diana, A., Doria, A., & Furlan, R. (2006). Increased neural sympathetic activation in fibromyalgia syndrome. Annals of New York Academy of Sciences, 1069, 109–117.
Shaver, J. L. (2004). Fibromyalgia in women. Nursing Clinics of North America, 39, 195–204.
Sicotte, N., Liva, S., Klutch, R., Pfeiffer, P., Odesa, W., Wu, T. C., et al. (2002). Treatment of multiple sclerosis with the pregnancy hormone estriol. Annals of Neurology, 52, 421–428.
Stuart, W. H., & Varmersch, P. (2004). Concomitant therapy for multiple Sclerosis. Neurology, 63, 528–534.
Transatlantic Multiple Sclerosis Genetics Cooperative. (2003). A meta-analysis of whole genome linkage screens in multiple sclerosis. Journal of Neuroimmunology, 143, 39–46.
Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic-pituitary-adrenal axis, neuro-endocrine functions and stress. Journal of Psychosomatic Research, 53 865–871.
Vukusic, S., & Confavreux, C. (2006). Pregnancy and multiple sclerosis: the children of PRIMS. Clinical Neurology and Neurosurgery, 108 206–270.
Vukusic, S., Hutchinson, M., Hours, M., Moreau, T., Cortinovie-Tourniaire, P., Adeleine, P., & Confavreux, C. (2004). Pregnancy and the PRIMS study: clinical predictors of post-partum relapse. Brain, 127 1353–1369.
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., et al. (1997). Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis and Rheumatism, 40 1571–1579.
Zhu, W., Lu, C., Huang, Y., Link, H., & Xiao, B. (2007). A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine, 2,3 dioxgenase by dendritic cells. Multiple Sclerosis, 13 33–40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Phelps, L. (2009). Critical Issues in Chronic Illnesses of Women. In: Fletcher-Janzen, E. (eds) The Neuropsychology of Women. Issues of Diversity in Clinical Neuropsychology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76908-0_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-76908-0_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-76907-3
Online ISBN: 978-0-387-76908-0
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)